FHAM
HAE icon

Folger Hill Asset Management’s Haemonetics HAE Stock Holding History

Folger Hill Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-45,000
Closed -$3.29M – 77
2018
Q1 		$3.29M Buy
+45,000
New +$3.09M 0.22% 148

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Folger Hill Asset Management's HAE Position: Q2 2018 in Review

Folger Hill Asset Management sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 45,000 shares — an estimated $3.29M sold.

Folger Hill Asset Management first reported a position in HAE in Q1 2018 and held it in 1 quarter. The position peaked at $3.29M in Q1 2018. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

  • Folger Hill Asset Management reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
  • Folger Hill Asset Management sold 45,000 Haemonetics shares in Q2 2018, an estimated $3.29M.
  • Folger Hill Asset Management first reported a position in Haemonetics in Q1 2018 and held it in 1 quarter.
  • Folger Hill Asset Management's Haemonetics position peaked at $3.29M in Q1 2018.
  • 293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Folger Hill Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.